Allantoxanamide - CAS 69391-08-8
Catalog number: B0084-391558
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C4H4N4O3
Molecular Weight:
156.1
COA:
Inquire
Targets:
Others
Description:
Allantoxanamide was reported to be a novel inhibitor of uricase in vivo.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-391558 10 mg $198 In stock
B0084-391558 50 mg $498 In stock
Bulk Inquiry
Purity:
95%
Synonyms:
4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxamide; 4,6-dioxo-1H-1,3,5-triazine-2-carboxamide; 4-Hydroxy-6-oxo-1,6-dihydro-1,3,5-triazine-2-carboxamide
MSDS:
Inquire
InChIKey:
HJXJVORILFDIOT-UHFFFAOYSA-N
InChI:
InChI=1S/C4H4N4O3/c5-1(9)2-6-3(10)8-4(11)7-2/h(H2,5,9)(H2,6,7,8,10,11)
Canonical SMILES:
C1(=NC(=O)NC(=O)N1)C(=O)N
1.Decreasing effect of allantoxanamide, a hyperuricemic agent on renal functions in rats.
Yonetani Y1, Iwaki K, Ogawa Y. Jpn J Pharmacol. 1987 Sep;45(1):37-43.
Both potassium oxonate and allantoxanamide have been reported as useful reagents for inhibiting urate oxidase, with the hyperuricemic effect of allantoxanamide being longer-lasting than that of oxonate in rats. The present study was done to evaluate the utility of allantoxanamide for investigating problems concerning hyperuricemia using rats. A single intraperitoneal administration of 150 mg/kg allantoxanamide elevated the plasma uric acid level progressively during the experiment for 6 hr, resulting in a much higher level than that maintained by means of repeated dosing with 250 mg/kg potassium oxonate, i.p., at 2-hr intervals. Such a severe and long-lasting hyperuricemia caused by allantoxanamide was due to decreased renal function of uric acid excretion according to its nephrotoxicity in addition to the inhibition of urate oxidase like that by oxonate. Thus, we concluded that allantoxanamide might be a useful reagent for investigating the causes of hyperuricemia with renal failure, but was not a practical agent like oxonate in order to evaluate the response to uricosuric agents.
2.Allantoxanamide-induced myocardial necrosis in Sprague-Dawley vs spontaneously hypertensive rats.
Wexler BC. Proc Soc Exp Biol Med. 1982 Sep;170(4):476-85.
3.Uricostatic effect of allopurinol in the allantoxanamide-treated rat: a new method for evaluating antiuricopathic drugs.
Hropot M, Muschaweck R, Klaus E. Adv Exp Med Biol. 1984;165 Pt A:175-8.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


AMG-747
(CAS: 1000690-85-6)

AMG-747 is a GlyT-1 inhibitor. It has been under investigation to treat various CNS disorders that may be ameliorated by modulation of either inhibitory glycine...

CAS 81110-73-8 Racecadotril

Racecadotril
(CAS: 81110-73-8)

Racecadotril is a peripherally acting enkephalinase inhibitor with an IC50 of 4.5 μM.

CAS 108825-65-6 Lin28 1632

Lin28 1632
(CAS: 108825-65-6)

Lin28 1632 is an RNA binding protein Lin28 inhibitor with IC50 value of 8 μM. It can inhibit growth of tumor cell lines and tumor-sphere formation in vitro.

Lavamilast
(CAS: 1218778-89-2)

Lavamilast is bio-active molecular as a PDE4 inhibitor but no detailed data has been published yet.

EN460
(CAS: 496807-64-8)

EN460 is a small molecule inhibitor by EN460 binding to ERO1α to promote the loss of flavin adenine dinucleotide (FAD) from the holoenzyme(IC50=1.9 uM) .

ISA-2011B
(CAS: 1395347-24-6)

ISA-2011B is a Phosphatidylinositol-4-phosphate 5-kinase-α (PIP5Kα) inhibitor. Research shows that the overexpression of PIP5K1α is associated with poor prognos...

AM-643
(CAS: 1233114-22-1)

AM-643 is an active molecular. In the Biological Tests, it can inhibit FLAP in human whole blood assessed as inhibition of calcium ionophore A23187-induced LTB...

A1B1 hydrochloride

A1B1 hydrochloride is a potent and orally-available chemokine CCR1 antagonist.

Chemical Structure

CAS 69391-08-8 Allantoxanamide

Quick Inquiry

Verification code

Featured Items